The properties of Ehrlich ascites tumour cells exposed in vivo to cadmium were investigated as a function of the zinc status of the host animals. Tumour-cell growth was inhibited by cadmium in both zinc-sufficient and zinc-deficient animals. However, cells in zinc-sufficient tumours accumulate much less cadmium than those in deficient tumours. The subcellular distributions of cadmium and zinc do not depend on zinc status. Cadmium and zinc are bound to a low-molecular-weight protein with properties similar to metallothionein. Without exposure to cadmium, a zinc-and copper-binding protein is still present that behaves like a metallothionein. This protein can rapidly bind cadmium added to Ehrlich cells in vitro. It is shown that the zinc-and copper-binding protein contains free thiol groups. Ehrlich cells isolated from cadmium-treated animals are viable and show normal incorporation of uridine into RNA, but the cellular uptake of thymidine and its incorporation into DNA are inhibited.
U.S.A., weighing approximately 30g and 8-11 weeks old at the onset of experiments, were housed in groups of five to seven animals in stainless steel wire cages over wood-chip bedding. A constant temperature of 250C was maintained in the animal room. An electronic timer maintained a 12 h light/12h dark cycle. Animals were fed ad libitum chow and drinking water with various amounts of zinc. Before the controlled diet, mice were fed Ralston Purina Laboratory Chow, which contains 70-90,ug of zinc/g, and tap water. During experiments requiring controlled levels of zinc, a zincdeficient chow obtained from Ziegler Bros., Gardiners, PA, U.S.A. (Murthy et al., 1975) with less than I,ug of zinc/g was employed, and the zinc intake was varied by the concentration of zinc in the glass-distilled water. Animals given 80,ug of zinc/ml are designated Zn(+) animals; those given no zinc are Zn(-) animals.
Chemicals
Eagle's minimal essential medium plus Earle's salts and Trypan Blue dye were obtained from Gibco. Imethvl-3HlThymidine, (1 mCi/ml; 2 Ci/ mmol) was purchased from Amersham-Searle, Arlington Heights, IL, U.S.A., and [ 3Hluridine (1 mCi/ml, 1 Ci/mmol) was received from Research Products Int. Corp., Elk Grove, IL, U.S.A. Sephadex G-75 (40-120,um particle size) was a product of Pharmacia Fine Chemicals, Uppsala, Sweden. 5,5'-Dithiobis-(2-nitrobenzoic acid) was obtained from Sigma. All other chemicals were reagent grade.
General procedures
The biuret reagent preparation and the method for protein concentration estimation was as described by Layne (1957) . Lysozyme and albumin (Sigma) were used as standards.
Cell counts were performed on an American Optical Spencer bright line phase haemacytometer (American Optical Corp., Buffalo, NY, U.S.A.).
To determine the extent of cell viability, 0.5 ml of the cell suspension used for the cell counts was used for a Trypan Blue exclusion text. Finally, acid digestion of cells and particulate fractions of cells was done so that cadmium and zinc analyses could be performed by atomic absorption spectroscopy. An aliquot of the tumour suspension was centrifuged, the supernatant was decanted. and the cell pellet was treated with 1.0ml of an acid digestion solution composed of 50% (v/v) HCI04, 30% (v/v) HNO3, and 20% (v/v) glass-distilled water. The mixture was heated in a water bath at 100°C overnight. In this and all other procedures described here glassware had been washed in 10% (v/v) HNO3 and then in 1 mM-EDTA to remove traces of contaminant metals.
Ehrlich ascites tumours, and cadmium and zinc treatment Ehrlich tumour cells were grown in female Swiss mice. Cells were introduced into animals by interperitoneal injection (0.1 ml injection/animal; approx. 107 cells). The tumour was allowed to grow in vivo in the mouse peritoneal cavity for 14 days. On days 5, 7, 9, 1 1, and 13, each animal received 0.l ml of 0.5 mM-CdCl2 or 10mM-ZnSO4 by intraperitoneal injection. On day 14, the animals were killed by cervical dislocation. This amount of cadmium was toxic to the animals, but was tolerated for the course of the experiment.
Tumour cells in ascites fluid were harvested by quantitative aspiration of the peritoneal contents into sterile 10ml syringes and deposited into disposable culture tubes. A drop of heparin (1000units/ml) was added to the culture tube to prevent agglutination. Cells and fluid were separated by centrifugation. Cells were freed of erythrocytes before being used for experiments. The tumour cells were resuspended in minimal essential medium of Ringer solution (0.9% NaCl/0.03% KCl/0.025% CaC12/0.02% NaHCO3), depending on the particular experiment. Cell counts and biuret tests for protein were routinely performed (see above).
The mice were individually weighed and the average weight change per mouse for that particular group was calculated. Changes in body weight are an index of tumour growth rate. Uptake ofcadmium by Ehrlich ascites cells in vitro Tumour cells from mice fed a normal zincsufficient diet and not injected with CdCl2 were studied for reaction with cadmium in vitro. Cells were harvested as above. From earlier experiments, it was decided to incubate the cells with 80ng-atoms of cadmium/mg of protein, which should result in an internal cell concentration of about 6 ng-atoms of cadmium/mg of protein (Solaiman et al., 1979) . Suspensions of cells and CdCl2 were always incubated for 20 min.
After incubation, the solution was centrifuged and the supernatant was removed. The cells were then resuspended in minimal medium or Ringer solution using a Supermixer. Cells were washed free of excess cadmium by repeating this procedure three more times before the cell contents were analysed for cadmium.
Preparation ofcellfractions
Differential centrifugation was used to determine the relative amounts of cadmium and zinc in the subcellular fractions. Six fractions were examined: 480 x g pellet (nuclei and unbroken cells), 480 x g nuclear supernatant, 12350 x g supernatant (mitochondrial supernatant), 149000 x g supernatant (soluble fraction), and 149000xg pellet (micro-somal fraction). Initial centrifugations were carried out in a Sorvall RC2B centrifuge (SS-34 rotor, 0-50C). Ultracentrifugation was done in a Beckman L5-75 preparative ultracentrifuge (fixed angle Ti-75 rotor). All samples of cells were sonicated gently on a Branson Sonifier Cell Disruptor 200 under pulsed mode, which allows some relaxation time for the cell. Output was set at 4, with a 30% duty cycle. The sample was sonicated for 30-90s, depending on the volume and concentration of the sample, in an ethanol/ice-slush bath to absorb excess shock and provide uniform temperature. The volume of sample homogenates was usually 9-12 ml.
The sonicated sample was transferred to a cold centrifuge tube and centrifuged at 480 x g for 10min.
The supernatant solution was carefully decanted into another centrifuge tube. The 480 x g pellet was resuspended in Ringer solution to a volume approx. equal to the volume of the original homogenate. This suspension was centrifuged at 270 x g in the refrigerated Sorvall centrifuge for 10min. The supernatant (nuclear supernatant) was decanted off and saved. The pellet was resuspended in Ringer solution and was designated the nuclear fraction. The initial supernatant from the above procedure was centrifuged at 12350 x g (10000 rev./min) for 10min. decanted and saved for separation of its constituents on a Sephadex column. The pellet was also saved for digestion and subsequent zinc and cadmium analyses. The supernatant was applied to a column (2.5cmx60cm) of Sephadex G-75 equilibrated with 0.01 M-phosphate buffer, pH 7.0. The column was then eluted with the same buffer at a rate of 20 ml/h. A series of molecular weight standards was used to calibrate the column. Fractions (4.5 ml) were collected and analysed as follows. First, absorbance was measured at 250 and 280nm with the Beckman Acta V spectrophotometer. Secondly, cadmium and zinc analyses on the fractions were performed by using an atomic absorption spectrophotometer. In a few cases, copper analyses were also done. Assays of the thiol content of the binding protein were done by adding 5,5'-dithiobis-(2-nitrobenzoic acid) (ElIman, 1959) .
As is described elsewhere, colour development is time-dependent, and the increase in absorbance at 412 nm must be followed until the reaction is complete in order to obtain valid results (Li et al., 1979) .
Utilization of 13Hlthvmidine and 13Hluridine bIi ascites cells
The utilization of [3Hlthymidine (a DNA precursor) and [3Hluridine (an RNA precursor) by Ehrlich ascites cells was measured by using a previously published procedure . Incubations were performed concurrently using cells from animal hosts on different regimes, each suspended at the same cell concentration to ensure valid comparison. Data are reported as a percentage of the total radioactivity recovered from extracellular, intracellular acid-soluble, and intracellular acid-precipitable compartments. Uncertainty in the reported value of the percentage of radioactivity recovered is less than +10% of the reported value. Incorporation of [3Hlthymidine or [3Hluridine into the HC104-insoluble compartment of cells was interpreted as a measure of DNA synthesis or RNA synthesis respectively. Radioisotope remaining in the extracellular medium after the incubation was used to evaluate the uptake of the precursor by the cells.
Results

Growth oftumour
Typical effects of cadmium, as CdCI2, on the growth of the Ehrlich tumour in mice given optimal and deficient levels of zinc in their diets are shown in Fig. 1 . Injections of 50ng-atoms of cadmium were given on days 7, 9, 11, and 13. This amount and interval of exposure of cells and animal to cadmium permitted the animals to survive until they were killed on day 14 and also allowed the growth of sufficient numbers of Ehrlich cells for the chemical and biochemical analyses described below. Fig. 1 shows that CdCl2 effectively inhibited the growth of the tumour cells with respect to control populations under both Zn(+) and Zn(-) conditions. Cadmium and zinc in Ehrlich cells and ascitesfluid 0, cadmium-injected animals given 80pg of zinc/ml of water; A, control animals given zero zinc in water; A, cadmium-injected animals given zero zinc in water. Cadmium (SOng-atom doses, as CdCI2) was injected intraperitoneally on days 7, 9, 11, and 13 (arrows).
somewhat depressed in zinc-deficient tumours in comparison with tumours in mice fed zinc-normal diets. Interestingly, when tumour-bearing mice are given four injections of I ,umol of ZnCI2 on days 7, 9, 11, and 13 after tumour implantation. the cellular concentration of zinc, 3.17 nmol/mg of protein, did not rise above control concentrations despite the nearly 2.5-fold higher zinc concentration of the fluid a day after the last injection.
In the presence of CdCI2, cellular and fluid zinc concentrations of tumours in the Zn(+) and Zn(-) animals did not change. The small variations are not statistically significant, as shown by the limits of measurement (Table 1 ). There was a dose dependence for the accumulation of cadmium by the Ehrlich cells. Over the range 100-200ng-atoms of cadmium, the cellular cadmium rose from 0.29 to 0.62ng-atoms/mg of protein. However, most striking is the finding that the total cadmium uptake is dependent on the zinc status of the tumour. Thus, Zn(+) tumours exposed to 200ng-atoms of cadmium had a cellular concentration of 0.35ng atoms of cadmium/mg of protein, much less than the 0.62 ng-atoms/mg seen in Zn(-) tumours, but similar to the amount in the tumour after lOOngatoms of cadmium in the zinc-deficient tumours. These differences are statistically signficant as shown by the error limits (Table 1 ). The zinc-deficient and zinc-sufficient tumours accumulate similar total amounts of cadmium (24 versus 34% of the total injected cadmium). Cadmium and zinc distributions in cells
The distribution of cadmium and zinc among cell fractions was then measured to see how the zinc Table 1 . Effect ofdietary zinc on cadmium and zinc uptake Cadmium was given in injections of 50ng-atom; for treatment with a total of 200ng-atoms, injections were given on days 7, 9, 11 and 13; for 150ng-atom, on days 9, 11 and 13; for lOOng-atom, on days 11 and 13. Zinc was given in injections of 10OOng-atom on days 7, 9, 11 and 13. Data are presented as means + S.E.M., with the number of samples in parentheses. Table 2 . Variation of the zinc available to the Ehrlich cells had no dramatic effect on either the zinc or cadmium distributions. About one-half of the cadmium was found in the particulate components of the cell and the other half in the supernatant. This observation also holds for zinc-deficient tumour cells subjected to 150ng-atoms of cadmium on days 7, 9, and 11 and examined on day 14 (results not shown). Cadmium was found in all of the cell fractions. When pellets of both nuclei and mitochondria were washed by resuspension and centrifugation, some cadmium remained bound to these fractions, whereas a portion of it was less firmly bound and was washed free of the pellets. The Sephadex G-75 profiles of zinc and cadmium in the 149 000 x g supernatant were then obtained.
Cadmium and zinc-binding protein fraction of supernatant Fig. 2 shows the typical pattern of zinc and cadmium in the effluent fractions from gel exclusion chromatography. In Ehrlich cells from either Zn(+) or Zn(-) tumours, cadmium was localized almost entirely in a protein fraction that behaved like a molecule of mol.wt. 10000 in this chromatographic system. There was little absorbance at 280nm associated with the fraction; however, more absorbance at 250nm was detected. In the zinc-sufficient animals, these fractions also contained large amounts of zinc. The average Zn/Cd atomic ratio was 2.8. These properties are consistent with the protein being a metallothionein. Nevertheless, firm identification will await further study. At present, it will be called a binding protein.
The cadmium-binding protein was also present under zinc-deficient conditions, as-illustrated in Fig.  2(b) . Furthermore, there was a marked alteration in the metal composition of the fraction; the Zn/Cd atomic ratio was drastically reduced to 0.65. Although this shift is partly due to an increase of cadmium in the fraction, it is principally due to a major decrease in the amount of zinc. Again, virtually all of the cadmium was localized to the binding protein.
Exposure of the tumour to extra zinc, as described in Table 1 , increases the amount of zinc in the 10000-mol.wt. area of the chromatographic effluent profile. An approx. 4-fold enhancement in the zinc content of the binding-protein fractions was observed. Increased amounts of zinc also appeared in higher and lower molecular weight fractions.
The finding that cadmium binds to a single cytosol fraction is in accord with many other studies demonstrating the presence of metallothionein in cells after exposure to cadmium. However, when the metal profile of the cytosol of Ehrlich cells untreated with cadmium was examined, the 10000-mol.wt. region of the chromatogram was occupied by a zinc-containing protein (Table 1 ). The overall profiles of Zn(+) and Zn(-) cell supernatants and the amount of zinc associated with the binding protein in zinc-normal and zinc-deficient cells are similar and are comparable with the level in the cadmium and zinc-binding protein in Fig. 2(a) .
Characterization of the cadmium-and zinc-binding protein
In some experiments, 5 mM-2-mercaptoethanol was added to the cell homogenate before Sephadex way. Fig. 4 shows that about 50% of the total reactive thiol groups react within the mixing time of > the assay mixture. This is followed by a much slower reaction. The initial reaction is characteristic of free thiol reacting with 5,5'-dithiobis-(2-nitrobenzoic acid), according to studies with horse-kidney 01 metallothionein (Li et al., 1979) . The second phase is similar to the reaction observed between 5,5'-dithiobis-(2-nitrobenzoic acid) and thiol groups bound to cadmium, zinc, or copper in the horse kidney protein (Li et al., 1979 . In tumours from zinc-deficient animals, not only was the incorporation of thymidine into DNA greatly depressed, but its uptake into the cells was also greatly inhibited. Patterns of movement of the label into cells and into DNA qualitatively similar to those observed in the Zn(-) tumour were seen in cells previously exposed to cadmium in the presence and absence of dietary zinc. In fact, both uptake and incorporation into DNA were suppressed to even a greater extent than in the control Zn(-) tumours.
Although there was a significant effect upon DNA synthesis that parallels the macroscopic inhibition of growth of these tumours by cadmium, there was no clear perturbation of RNA synthesis, as measured by [3Hluridine incorporation into RNA (Fig. 7) . These results agree with earlier studies that zinc deficiency alone does not alter either uptake or incorporation of radioactive label into RNA . The experiments of Figs. 6 and 7 was assessed using a dye exclusion test with Trypan Blue. In all cases, viability was greater than 95%. Therefore, there appeared to be a selective effect of cadmium upon the mechanism of DNA synthesis in the liver Ehrlich cells.
Discussion
The studies described here were begun with the hypothesis that Ehrlich ascites tumour could be used as a model for the examination of the interactions of cadmium with cells. This was substantiated by the finding that Ehrlich cells exposed to CdCl2 in vivo bind virtually all their cytoplasmic cadmium in a single protein that has properties similar to mammalian metallothioneins, which are known to bind cytosolic cadmium, zinc, and traces of copper. These findings are similar to those reported by Rudd & Herschman (1978) and by Hidalgo et al. (1978b) . HeLa cells in culture, and a mouse hepatoma, both incorporate cadmium into a metallothionein-like protein. Furthermore, the hepatoma cells normally contain a zinc-binding protein described as a metallothionein, although no copper was found in the material. Ehrlich cells, too, normally contain a zinc-and copper-binding protein basically having the same properties as the cadmium-binding protein described above.
The exposure of these cells to cadmium may simply lead to the binding of metal to pre-existent protein, not to the induction of new binding protein, as occurs when rat liver encounters cadmium ion (Andersen et al., 1978; Richards & Cousins, 1975 , although the 33% decrease in zinc content of tumour cells in Zn(-) animals was not observed earlier. There is no marked, repeatable difference in the profile of the zinc in cell cytosol or particulate fraction between Zn(+) or Zn(-) tumours ( Fig. 5 and Table 2 ). Thus, the effects of zinc deficiency on Ehrlich cells documented elsewhere are not paralleled by noticeable losses of zinc from the cells or shifts between cellular components.
After the discovery of a naturally occurring zinc-binding protein in Ehrlich cells, it was found that isolation and Sephadex chromatography of cell supernatant in the presence of 2-mercaptoethanol eliminates the presence of the low-molecular-weight band of protein-bound zinc observed in Fig. 2 , as can be seen in Fig. 3 . The basis for the inclusion of 2-mercaptoethanol came from current studies with rat-liver metallothionein, which show that the protein is readily oxidized during preparation, losing some of its zinc into a lower-molecular-weight fraction (D. T. Minkel, K. Paulsen, S. Wielgus, C. F. Shaw & D. H. Petering, unpublished work) . When isolated in the presence of 2-mercaptoethanol, the binding protein contains the majority of the cytoplasmic copper. Interestingly, it is bound in stable form even under aerobic conditions, which for simple systems containing Cu(II) or Cu(I) and thiols would lead to thiol oxidation (Jocelyn, 1972) . The finding of large amounts of both zinc and copper in a metallothionein-like protein raises the possibility that copper and zinc metabolism interact in this protein fraction, as has been suggested by other workers (Evans et al., 1970) .
Treatment of zinc-deficient tumours with massive amounts of zinc does not raise their cellular zinc concentration measurably above that of tumours from Zn(+) animals. The fact that ascites-fluid zinc concentrations vary over an 8-fold range between Zn(-) cells and cells exposed to excess metal, whereas the cellular zinc concentration only increases from 2.16 to 3.17 ng/atoms/mg of protein confirms that there is no detectable equilibration of cellular and fluid pools of zinc in the tumour . Nevertheless, the amount of zinc bound to binding protein does increase above that found in either Zn(-) or Zn(+) tumours (Fig. 5) . Ohtake et al. (1978) recently found that rat liver cells stimulated to divide by a drug-hormone combination and by partial hepatectomy generate a large amount of new zinc-metallothionein. They suggested that its induction might be a requirement for carrying out DNA synthesis as the liver moves from a resting state into the S-phase of the cell cycle. The finding of zinc-and copper-binding protein in rapidly-dividing tumour cells may signal a similar requirement. However, the protein is still present in Zn(-) tumours (Fi. 2b) which grow much more slowly and apparently contain a large proportion of resting cells . The Turning to the interaction of cadmium and zinc in Ehrlich cells, the presence of cadmium in the tumour does not alter the total cellular zinc content relative to control values (Table 2 ). However, the cadmium content of the cells is a function of the zinc status of the tumour. Almost twice as much cadmium/mg of cell protein is present in the Zn(-) tumour as in the Zn(+) cells. Indeed, although the tumours from zinc-deficient animals contain only about one-third the number of the cells of the zinc-normal tumours, they accumulate two-thirds of the same total dose of cadmium.
Although the total cadmium content varies depending on zinc status, the relative distribution among the cell fractions does not vary. About 50% of the total cadmium is found in the particulate fractions of the cell, 40% of which is not removed by washing the pellet ( leads not only to cadmium in the binding protein, but also to a much increased content of zinc in the band (Fig. 2) .
Finally, some functional effects of cadmium on EhrLich cells have been observed. Incorporation of thymidine into DNA is inhibited in cadmiumexposed, Zn(+) cells and even more so in the Zn(-) tumours treated with cadmium. Total uptake of thymidine into Ehrlich cells is also decreased in the presence of cadmium. These cell populations are viable according to Trypan Blue staining, and show incorporation of uridine into RNA approx. the same as in control tumours not exposed to cadmium. Hence, there is selectivity to the alterations of metabolism caused by cadmium. This is also suggested by our unpublished studies of the rates of respiration of Ehrlich cells from control and cadmium-exposed tumours. Although oxidative phosphorylation in isolated Ehrlich mitochondria is inhibited by low concentrations of cadmium, only a 25% decrease in the rate of oxygen utilization is seen in the cadmium-treated cell populations either from zinc-normal or zinc-deficient animals. These results are similar to the earlier findings that short-term incubations of Ehrlich cells with cadmium produces only a minor effect on cell respiration (Solaiman et al., 1979) .
Comparing the concentration-dependence of the effects of cadmium upon thymidine metabolism in these Zn(+) cells with cells exposed for only 1 h to cadmium, as examined by Solaiman et al. (1979) , it is seen that inhibition of incorporation of thymidine into DNA occurs at a much lower internal concentration of cadmium (0.32 versus 3.2ng-atoms/ mg of cell protein) and with a corresponding inhibition of uptake of the nucleoside which does not occur after exposure to cadmium in vitro (Solaiman et al., 1979) . This implies a slow reorganization of heavy metal after intial exposure of the cells, which leads to a different mode of suppression of DNA synthesis.
The effects of cadmium upon macromolecular synthesis in Zn(+) cells are the same as those in zinc-deficient cells . In that case, it was suggested that the depression of DNA synthesis in Zn(-) cells is due to a decrease in the population of cells proceeding through the cell cycle.
A similar mechanism may be operative here. The intriguing possibility is that in cadmium exposure, there is a direct cadmium-zinc interaction such that cadmium-treated Zn(+) cells behave like Zn(-) cells.
A direct antagonism between cadmium and zinc has been suggested in previous animal experimentation (Petering, 1978) . What is new here is that there is defined a specific biochemical process (the incorporation of thymidine into DNA) that may be subject to this competitive relationship.
